Results 131 to 140 of about 4,934 (166)

[Synthetic phenolic compounds perturb lipid metabolism and induce obesogenic effects]. [PDF]

Se Pu
Liu HN, Sun ZD, Liu Q, Zhou QF, Jiang GB.   +4 more
europepmc   +1 more source

[Metabolomic alterations in preterm infants with bronchopulmonary dysplasia]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wu YY, Bu QQ, Wang X, Li T, Wu HY, Kang L, Wang YY, Liu DP, Guo J, Wang CJ, Kang WQ.   +10 more
europepmc   +1 more source

[<i>Jiangzhi Quban</i> Recipe improves type 2 diabetes mellitus complicated with hyperlipidemia by multi-target regulation of the inflammation-metabolism network: network pharmacology analysis and clinical validation]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li Z, Zhou F, Sun X, Zhao H, Jin Y, He P, Jia Y.   +6 more
europepmc   +1 more source

[Plasma lipidomics-based exploration of potential biomarkers of metastasis in pediatric medulloblastoma]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Yang CJ, Xu XQ, Bao L, Wu WS, Jiang DC, Shi ZY.   +5 more
europepmc   +1 more source

[Research Progress on the Role and Regulatory Mechanisms of Lipid Metabolism in the Osteogenic/Odontogenic Differentiation of Dental Stem Cells]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
An K, Xie J, Zhou X.
europepmc   +1 more source

[EVA1A overexpression improves non-alcoholic fatty liver disease in mice by regulating lipid metabolism and promoting lipophagy]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Xu J, Yang D, Zang K, Chu M, Zhao Q, Li Q, Lu S, Chen X, Li N.   +8 more
europepmc   +1 more source

[Untargeted metabolomics reveals differential serum metabolites and metabolic pathways in patients with primary Sjögren syndrome and thrombocytopenia]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Xiang Z, Yang L, Yang J.
europepmc   +1 more source

[Progress in metabolomics of multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Ye X, Sun ZX, Qu XY, Fan L.
europepmc   +1 more source

[Research progress on cellular metabolic reprogramming in skin fibrosis]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Qian S, Dai S, Guo C, Xu J.
europepmc   +1 more source

[Exposures to volatile organic compounds are positively correlated with risks of metabolic dysfunction-associated steatotic liver disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li K, Zeng W, Zhang Y, Zhu X, Guo B.
europepmc   +1 more source